Paper2524554
Heparin and heparan sulfate partially inhibit induction of acetylcholine receptor accumulation by nerve in Xenopus culture.
Hirano Y and 1 other. J Neurosci, 1989. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Heparin and heparan sulfate partially inhibit induction of acetylcholine receptor accumulation by nerve in Xenopus culture. Papers, record 2524554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2524554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycosaminoglycans | Major topic |
| Heparin | Major topic |
| Heparan Sulfate | Major topic |
| Nerve Tissue | Major topic |
| Neural Inhibition | Major topic |
| Receptors, Cholinergic | Major topic |
| Animals | |
| Cells, Cultured | |
| Chondroitin Sulfates | |
| Muscles | |
| Neuromuscular Junction | |
| Time Factors | |
| Xenopus |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NS 23753 | NINDS NIH HHS | United States | R01NS023753 | PubMed and NIH |
Source NIH RePORTER
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 10818145 | Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies. | J Neurosci | 2000 | https://conductscience.org/library/papers/10818145 | PubMed |
| 9698325 | alpha-Dystroglycan functions in acetylcholine receptor aggregation but is not a coreceptor for agrin-MuSK signaling. | J Neurosci | 1998 | https://conductscience.org/library/papers/9698325 | PubMed |
| 8656273 | Neural agrin activates a high-affinity receptor in C2 muscle cells that is unresponsive to muscle agrin. | J Neurosci | 1996 | https://conductscience.org/library/papers/8656273 | PubMed |
| 8027170 | Agrin-induced clustering of acetylcholine receptors: a cytoskeletal link. | J Cell Biol | 1994 | https://conductscience.org/library/papers/8027170 | PubMed |
| 8026466 | Structural domains of agrin required for clustering of nicotinic acetylcholine receptors. | EMBO J | 1994 | https://conductscience.org/library/papers/8026466 | PubMed |
| 7860635 | Acetylcholine receptor-aggregating activity of agrin isoforms and mapping of the active site. | J Cell Biol | 1995 | https://conductscience.org/library/papers/7860635 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2524554
GET https://conductscience.org/api/papers/v1/2524554/authors